SEC Form 4 · accession 0001193125-26-292685
Aura Biosciences, Inc. · AURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Conor Kilroy
Officer — See Remarks
Period of report
Jul 1, 2026
Accepted (ET)
Jul 1, 2026 · 4:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001501796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2026 | A | 14,858 | $0.00 | A | 232,693 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in two substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.
Remarks
Chief Legal Officer and Secretary